|
OMB APPROVAL
|
||||
|
OMB Number:3235-0167
|
||||
|
UNITED STATES
|
Expires:November 30, 2010
|
|||
|
SECURITIES AND EXCHANGE COMMISSION
|
Estimated average burden
|
|||
|
Washington, D.C. 20549
|
hours per response
1.50
|
|
Patient Portal Technologies, Inc.
|
|
(Exact name of registrant as specified in its charter)
|
|
8276 Willett Parkway, Suite 200, Baldwinsville, New York 13027 Phone: (315) 638-6708
|
|
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
|
|
Common Stock, $.001 Par Value
|
|
(Title of each class of securities covered by this Form)
|
|
N/A
|
|
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
|
|
Rule 12g-4(a)(1)
|
x
|
||
|
Rule 12g-4(a)(2)
|
o
|
||
|
Rule 12h-3(b)(1)(i)
|
x
|
||
|
Rule 12h-3(b)(1)(ii)
|
o
|
||
|
Rule 15d-6
|
o
|
|
Date:
October 12, 2010
|
By: Kevin Kelly, Chief Executive Officer
|
|
Persons who respond to the collection of information contained
|
||
|
in this form are not required to respond unless the form displays
|
||
|
SEC2069(02-08)
|
a currently valid OMB control number.
|